Clinical Evidence Supporting GLM for Joint Health in Pets

1. Improved Mobility and Pain Reduction

  • A study published in the Canadian Journal of Veterinary Research evaluated 23 dogs with OA. After 60 days on a GLM-enriched diet, dogs showed significant improvements in gait (measured by peak vertical force), increased plasma omega-3 levels, and reduced pain scores compared to a control diet.

Clinical Evidence Supporting GLM

2. Reduction in Arthritic Symptoms

  • In a double-blind study involving 31 dogs, those fed a diet supplemented with 0.3% GLM powder for six weeks exhibited significant reductions in total arthritis scores, particularly in joint pain and swelling, compared to the control group 

Clinical Evidence Supporting GLM

3. Comparable Efficacy to NSAIDs

  • A randomised, placebo-controlled trial compared GLM extract (EAB-277) to the NSAID meloxicam in dogs with hip OA. Both treatments led to significant improvements in limb use (measured by peak vertical force), with GLM showing similar efficacy to meloxicam over a six-week period .

Clinical Evidence Supporting GLM

4. Enhanced Quality of Life

  • A study reported that 83% of dogs receiving GLM supplementation demonstrated a 30% or greater reduction in total arthritic scores, indicating improved mobility and reduced discomfort.

Clinical Evidence Supporting GLM

 

Wholesale